Related Experiment Video
Updated: Dec 25, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
[Association between CD40-CD40L system and obesity in children]
1Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310051, China. zcc14@zju.edu.cn.
Insights
The CD40-CD40L system is linked to childhood obesity, hyperlipidemia, and hypertension. These markers may help in early detection of metabolic syndrome and guide treatment strategies.
Area of Science:
- Pediatrics
- Immunology
- Metabolic Health
Background:
- Childhood obesity is a growing public health concern.
- The CD40-CD40L pathway plays a role in immune and inflammatory responses.
- Understanding the link between CD40-CD40L and obesity is crucial for metabolic health.
Purpose of the Study:
- To investigate the association between the CD40-CD40L system and obesity in children.
- To explore the relationship of CD40 and CD40L with clinical and biochemical parameters in obese children.
Main Methods:
- A case-control study involving 76 obese children and 74 healthy controls.
- Comparison of morphological indices, biochemical parameters, and serum CD40/CD40L levels.
- Statistical analyses including partial correlation and multivariate linear regression.
Main Results:
- Obese children showed significantly higher BMI, blood pressure, lipid profiles (except HDL), liver enzymes, uric acid, fasting glucose, insulin, HbA1c, platelets, and CD40L compared to controls.
- CD40L levels positively correlated with weight, BMI, blood pressure, and various lipid/biochemical markers.
- CD40 levels correlated with waist-height ratio and platelet count.
Conclusions:
- The CD40-CD40L system is significantly associated with childhood obesity, hyperlipidemia, and hypertension.
- CD40 and CD40L may serve as early warning indicators for metabolic syndrome.
- This research offers insights for preventing and managing related chronic diseases.
Objective:
To study the association between CD40-CD40L system and obesity in children.
Methods:
A total of 76 obese children were enrolled as the obese group, and 74 healthy children with normal body mass index (BMI) were enrolled as the control group. The two groups were compared in terms of morphological indices, biochemical parameters, and serum levels of CD40 and CD40L. Partial correlation analysis and multivariate linear regression analysis were performed to investigate the correlation of CD40 and CD40L with other clinical indices.
Results:
Compared with the control group, the obese group had significantly higher BMI, waist circumference/height ratio, systolic pressure, diastolic pressure, alanine aminotransferase (ALT), aspartate aminotransferase (AST), uric acid, triglyceride, apolipoprotein B, fasting blood glucose, fasting insulin, glycosylated hemoglobin, platelet count, CD40L, and mean carotid intima-media thickness (P<0.05), but significantly lower high-density lipoprotein cholesterol and apolipoprotein A1 (P<0.05). With age and sex as the control factors, the partial correlation analysis showed that CD40L was positively correlated with height, weight, BMI, diastolic pressure, bile acid, triglyceride, total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, and platelet count (P<0.05). CD40 was positively correlated with waist circumference/height ratio and platelet count (P<0.05). The multivariate linear regression analysis showed that ALT, AST, total cholesterol, and platelet count were the dependent factors influencing the level of CD40L (R2=0.266, P<0.05).
Conclusions:
CD40-CD40L system is closely associated with obesity and related hyperlipidemia and hypertension. CD40 and CD40L may be used as new indicators for early warning of metabolic syndrome and provide new ideas for the prevention and treatment of related chronic diseases.
More Related Videos
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

